Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Intussusception Market Growth in 2025?

The market size for intussusception has experienced significant growth in the past few years. It is projected to expand from $4.45 billion in 2024 to $4.69 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.3%. Factors such as enhanced diagnostic abilities, heightened awareness and education, development of worldwide healthcare infrastructure, research and development funding, and collaborations amongst healthcare stakeholders have all contributed to the growth experienced in the previous era.

What Is the Forecast for the Intussusception Market Size Through 2029?

The market size for intussusception is projected to experience a consistent expansion in the upcoming years, with expectations to reach $5.52 billion in 2029, growing at a compound annual growth rate (CAGR) of 4.1%. Factors contributing to this predicted surge during the forecast period include ongoing medical education efforts, pediatric inoculation initiatives, worldwide endeavors in pediatric healthcare, emphasis on after-care post-surgery, increasing demand for pediatric gastrointestinal research, and access to telemedicine and remote healthcare. Key trends during the estimated period comprise progress in diagnostic imaging, a penchant for minimally invasive treatment techniques, formulation of pediatric-focused interventions, exploration of cause and risk influences, worldwide epidemiological investigations, implementation of immunization programmes, and utilization of telemedicine for diagnosis and consultative purposes.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13466&type=smp

What are the Key Market Players in Intussusception Market and How They’re Evolving?

Major companies operating in the intussusception market report are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Abbott Laboratories, Sanofi S.A., GlaxoSmithKline PLC, Stryker Corporation, Boston Scientific Corporation, Biogen Inc., Olympus Corporation, GE HealthCare Technologies Inc., Steris PLC, Cook Medical LLC, Shimadzu Corporation, Carestream Health, CONMED Corporation, Janssen Pharmaceuticals Inc., EndoChoice Holdings Inc., Fujifilm Healthcare Solutions, Basilea Pharmaceutica Ltd., Richard Wolf GmbH, Karl Storz SE And Co. KG, Eizoflex Co. Ltd., Arena Pharmaceuticals Inc.

What Are the Primary Growth Drivers in the Intussusception Market?

The surge in instances of intestinal maladies is anticipated to fuel the intussusception market’s growth in the future. Intestinal disorders encompass any health complications that disrupt the regular performance of the intestines, a crucial component of the digestive system accountable for nutrient absorption and waste removal from the body. The escalating occurrence of such disorders, including inflammatory bowel disease and gastrointestinal cancers, may facilitate earlier detection, enhanced therapeutic strategies, and augmented assistance for individuals suffering from intussusception, thereby promoting their overall health and wellness. For instance, based on data from the American Cancer Society (ACS), a health organization in the US dedicated to cancer eradication, it was reported in January 2023 that gastrointestinal cancers in the United States saw a rise of 3.18% to 348,840 from 338,090 in 2021. Thus, the escalating occurrence of intestinal disorders contributes to driving the growth of the intussusception market. Escalating expenditures in healthcare are catalyzing the growth of the intussusception market. Healthcare expenditure refers to the comprehensive amount of financial resources assigned to the medical sector within a certain geographical region or institution. The allocation of these resources serves to cater to medical needs, and the prevalence of conditions such as intussusception demand medical interventions, diagnostic techniques, and potential surgical procedures. These factors influence healthcare costs significantly. As an example, the Canadian Institute for Health Information reported in November 2023 that the total healthcare expenditure in Canada for 2023 is expected to touch $344 billion or $8,740 per person. This represents a 2.8% increment compared to the previous year, which saw only a 1.5% increase in health spending in 2022. This trend showcases a considerable resurgence in healthcare investments. Hence, the escalating expenditure in healthcare is accelerating the growth of the intussusception market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13466&type=smp

What Are the Leading Segments in the Global Intussusception Industry?

The intussusception market covered in this report is segmented –

1) By Type: Idiopathic Intussusception, Secondary Intussusception

2) By Treatment: Enema Reduction, Surgery, Other Treatment

3) By Diagnosis: Barium Enema, Ultrasound, X-Ray, Computerized Tomography (CT)

4) By End-User: Hospitals, Clinics, Other End-User

Subsegments:

1) By Idiopathic Intussusception: Childhood Idiopathic Intussusception, Adult Idiopathic Intussusception

2) By Secondary Intussusception: Neoplastic Intussusception, Infectious Intussusception, Inflammatory Intussusception, Post-Surgical Intussusception

What Are the Key Market Trends in the Intussusception Industry?

Key players in the intestinal pseudo-obstruction treatment market are innovating with new drug treatments such as NHE3 inhibitor treatment therapy to offer dependable solutions to their clients. This therapy functions by obstructing the Sodium-Proton-Exchanger subtype 3 (NHE3) within the digestive system. As an illustration, Ardelyx Inc., an American biopharmaceutical firm, launched IBSRELA, an NHE3 inhibitor treatment for adult irritable bowel syndrome with constipation (IBS-C), in April 2022, potentially enhancing gastrointestinal mobility. The IBSRELA therapy works by counteracting or suppressing the activity of the Sodium-Hydrogen Exchanger 3 (NHE3) protein. The authorization of IBSRELA was built on the results of two Phase 3 trials conducted on over 1,200 IBS-C patients. It notably ameliorated abdominal discomfort and bowel movement, achieving the primary objective, with notable improvements noted as early as the first week and consistently up to 26 weeks in the extended trial.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/intussusception-global-market-report

What Is the Regional Outlook for the Intussusception Market?

North America was the largest region in the intussusception market in 2024. The regions covered in the intussusception market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13466

This Report Delivers Insight On:

1. How big is the intussusception market, and how is it changing globally?

2. Who are the major companies in the intussusception market, and how are they performing?

3. What are the key opportunities and risks in the intussusception market right now?

4. Which products or customer segments are growing the most in the intussusception market?

5. What factors are helping or slowing down the growth of the intussusception market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model